New Delhi: The second batch of Russian vaccine Sputnik V landed at the Hyderabad airport on Sunday morning.
Hyderabad-based Dr Reddy’s Laboratories has tied up with the Russian Direct Investment Fund (RDIF) for the vaccine’s distribution in India.
Sputnik V is the third vaccine in India to receive emergency use approval, besides Bharat Biotech’s Covaxin and Covishield of the Pune-based Serum Institute of India.
Ambassador Kudashev said that life-saving humanitarian assistance delivered last month by the Russian side is being successfully used to help Indians to overcome the consequences of the disease.
“That is indeed a brilliant example of the special and privileged strategic partnership and an effective model of international anti-pandemic cooperation that does not know any unnecessary obstacles,” he said.
Sputnik V was approved for use in India on April 12, 2021 and granted an emergency use authorisation.
